Report: 40% of European epilepsy patients receiving inadequate care
A new report from Angelini Pharma has highlighted an ongoing treatment gap for epilepsy care in Europe, including significant differences in access to treatment between countries.
Jacopo Andreose Angelini Pharma Elisa Milani International Bureau Of Epilepsy Brain Health European House
Source: biopharma-reporter.com